Valvular & structural heart disease
Comparison of Transcatheter Versus Surgical Tricuspid Repair Among Patients With Tricuspid Regurgitation: Two-Year Results
Main findingResult — go to the resultAdjusted hazard ratio 0.84 95% CI 0.63–1.13Authors' conclusion
Among Medicare beneficiaries with TR, the 2-year mortality rate was comparable between T-TEER and surgical repair. T-TEER showed advantages in perioperative outcomes, including lower in-hospital mortality and pacemaker implantation rates, whereas tricuspid valve reinterventions were more frequent in the T-TEER group.
Study context
- Population
- Medicare fee-for-service beneficiaries aged 65 to 99 years with tricuspid regurgitation (TR), July 2016–December 2020
- Participants
- 1,143 beneficiaries
- Exposure
- T-TEER vs surgical tricuspid valve repair
- T-TEERn = 409
- Surgeryn = 734reference
- Outcome
- All-cause mortality
- Follow-up
- 2 years
Methodological detailspropensity score matching weight analysis
- Propensity score matching weight analysis
Main finding
As reported in the abstract
Adjusted hazard ratio
0.84
95% CI 0.63–1.13
T-TEERvs Surgery
adjusted HR 0.84 (95% CI 0.63–1.13)
Observational data: associations, not effects.
Further findings
In-hospital mortality
P < 0.001
HF hospitalization · 2 years
- No differences in HF hospitalizations
Proportion of T-TEER among isolated TR procedures
- Increased from Q3 2016 to last quarter of 2020
- 2% to 67%
Safety
Permanent pacemaker implantation
P < 0.001
| Outcome | Subdistribution HR (95% CI) | |
|---|---|---|
| Tricuspid valve reintervention · 2 yearsMore frequent with T-TEER | 8.03 (2.87–22.48) | |
| 0.050.21520Subdistribution hazard ratio (log scale) |
Original publication
Comparison of Transcatheter Versus Surgical Tricuspid Repair Among Patients With Tricuspid Regurgitation: Two-Year Results. Circ Cardiovasc Interv. Published 18 November 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →